Could Risk Stratifying MTX Users Lead to Testing Less Often?
A new prognostic model accurately predicts a patient’s risk of experiencing methotrexate toxicity, but more research is needed before clinical application, experts say.
Medscape Medical News
source https://www.medscape.com/viewarticle/994926?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/994926?src=rss
Comments
Post a Comment